Trial Profile
Outpatients high-dose chemotherapy supported by autologus peripheral blood stem and single-dose pegfilgrastim in patients with lymphoproliferative malignances.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2011
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Chronic lymphocytic leukaemia; Diffuse large B cell lymphoma; Hodgkin's disease; Lymphoproliferative disorders; Multiple myeloma
- Focus Adverse reactions
- Acronyms PEG-HSR
- 07 Jul 2011 New trial record